Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

NIH 13OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2Other hematologic neoplasm 2Lymphoid 1Genitourinary 1Dermatologic 1Breast 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 2

Interventions

Cisplatin 60Carboplatin 55Cyclophosphamide 47Pemetrexed 45Irinotecan 33pembrolizumab 32Paclitaxel 29Etoposide 29Gemcitabine 28Nivolumab 24Bevacizumab 24Interviews as Topic 23Vincristine 22Capecitabine 22Topotecan 20Filgrastim 20Early Intervention, Educational 20fludarabine 19Oxaliplatin 19Docetaxel 19Specimen Handling 18Drug Therapy 18Temozolomide 17Sorafenib 17Leucovorin 17Everolimus 17Educational Status 17Radiotherapy 16Methods 16Fluorouracil 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × alvocidib × Other solid neoplasm × Clear all
NCT00003004 2013-06-24

Combination Chemotherapy in Treating Patients With Refractory or Recurrent Solid Tumors

Memorial Sloan Kettering Cancer Center

Phase 1 Completed
73 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00016185 2013-04-05

Flavopiridol and Docetaxel in Treating Patients With Advanced Solid Tumors

Barbara Ann Karmanos Cancer Institute

Phase 1 Completed
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡